Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Invivyd Inc. (NASDAQ : IVVD) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.
Quote
| Last: | $1.035 |
|---|---|
| Change Percent: | -8.0% |
| Open: | $1.13 |
| Close: | $1.125 |
| High: | $1.13 |
| Low: | $1.03 |
| Volume: | 2,397,230 |
| Last Trade Date Time: | 06/05/2026 12:45:50 pm |
Stock Data
| Market Cap: | $379,990,219 |
|---|---|
| Float: | 86,954,817 |
| Insiders Ownership: | 0.02% |
| Institutions: | 28 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.invivyd.com |
| Country: | US |
| City: | New Haven |
Recent News Releases
Subscribe to Our Newsletter
Message Board Posts
**MWN-AI FAQ is based on asking OpenAI questions about Invivyd Inc. (NASDAQ: IVVD).


